These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1587751)

  • 1. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
    Mohiuddin M; Rosato F; Barbot D; Schuricht A; Biermann W; Cantor R
    Int J Radiat Oncol Biol Phys; 1992; 23(2):305-11. PubMed ID: 1587751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
    Mohiuddin M; Cantor RJ; Biermann W; Weiss SM; Barbot D; Rosato FE
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):79-84. PubMed ID: 3121546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
    Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
    J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
    Schuricht AL; Spitz F; Barbot D; Rosato F
    Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinoma of the pancreas--the Jefferson experience 1975-1988.
    Mohiuddin M; Rosato F; Schuricht A; Barbot D; Biermann W; Cantor R
    Eur J Surg Oncol; 1994 Feb; 20(1):13-20. PubMed ID: 8131862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.
    Mohiuddin M; Regine WF; Stevens J; Rosato F; Barbot D; Biermann W; Cantor R
    J Clin Oncol; 1995 Nov; 13(11):2764-8. PubMed ID: 7595736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
    Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
    Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
    Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
    Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282.
    Cohen SJ; Dobelbower R; Lipsitz S; Catalano PJ; Sischy B; Smith TJ; Haller DG;
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1345-50. PubMed ID: 16029791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
    Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
    Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoradiation with or without intraoperative radiation therapy in patients with locally recurrent rectal carcinoma: prognostic factors and long term outcome.
    Valentini V; Morganti AG; De Franco A; Coco C; Ratto C; Battista Doglietto G; Trodella L; Ziccarelli L; Picciocchi A; Cellini N
    Cancer; 1999 Dec; 86(12):2612-24. PubMed ID: 10594856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study.
    Jin Z; Du Y; Li Z; Jiang Y; Chen J; Liu Y
    Endoscopy; 2008 Apr; 40(4):314-20. PubMed ID: 18283622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
    Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
    Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer.
    Alden ME; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):945-51. PubMed ID: 8138448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modality therapy for stage II and stage III pancreatic carcinoma.
    Kamthan AG; Morris JC; Dalton J; Mandeli JP; Chesser MR; Leben D; Cooperman A; Bruckner HW
    J Clin Oncol; 1997 Aug; 15(8):2920-7. PubMed ID: 9256136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodality therapy of localized unresectable pancreatic adenocarcinoma.
    Whittington R; Solin L; Mohiuddin M; Cantor RI; Rosato FE; Biermann WA; Weiss SM; Pajak TF
    Cancer; 1984 Nov; 54(9):1991-8. PubMed ID: 6478433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.